Two Sigma Advisers’s Core Laboratories CLB Stock Holding History

Two Sigma Advisers’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-2,000	Closed	-$293K	–	2460
2014 Q3	$293K	Buy	+2,000	New	+$309K	﹤0.01%	1881

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Two Sigma Advisers's CLB Position: Q4 2021 in Review

Two Sigma Advisers sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 9,900 shares — an estimated $275K sold.

Two Sigma Advisers first reported a position in CLB in Q2 2017 and held it in 10 quarters. The position peaked at $9.61M in Q2 2018. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

Two Sigma Advisers reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
Two Sigma Advisers sold 9,900 Core Laboratories shares in Q4 2021, an estimated $275K.
Two Sigma Advisers first reported a position in Core Laboratories in Q2 2017 and held it in 10 quarters.
Two Sigma Advisers's Core Laboratories position peaked at $9.61M in Q2 2018.
174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.